Skip to main content

Day: December 10, 2020

Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.

FDA expected to make a decision on Emergency Use Authorization in the coming daysPositive vote based on totality of scientific evidence presented by the companies, including Phase 3 efficacy and safety dataIf authorized, BNT162b2 would be the first COVID-19 vaccine available in the U.S.NEW YORK and MAINZ, GERMANY, December 10, 2020 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted (17 to 4) in support of the FDA granting Emergency Use Authorization (EUA) for the companies’ COVID-19 mRNA vaccine (BNT162b2). There is one member of the Committee whose vote is not included in the 17 to 4 vote decision.VRBPAC based its recommendation on the totality of scientific evidence shared by the companies,...

Continue reading

FDA-Beratungsausschuss unterstützt die erste U.S.-Notfallzulassung für Pfizers und BioNTechs COVID-19-Impfstoff

FDA wird voraussichtlich innerhalb der nächsten Tage eine Entscheidung bezüglich einer Notfallzulassung treffenDas positive Abstimmungsergebnis basiert auf der Gesamtheit der eingereichten wissenschaftlichen Daten, einschließlich der Phase-3-Daten zu Wirksamkeit und SicherheitIm Falle einer Zulassung wäre BNT162b2 der erste in den USA verfügbare COVID-19-ImpfstoffNEW YORK, USA und MAINZ, Deutschland, 10. Dezember 2020 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX) gaben heute bekannt, dass sich das Vaccines and Related Biological Products Advisory Committee (VRBPAC) der U.S. Food and Drug Administration (FDA) für eine Erteilung (17 zu 4 Stimmen) der Notfallzulassung ihres mRNA-basierten COVID-19-Impfstoffs (BNT162b2) durch die FDA ausgesprochen hat. Bei der Abstimmung gab es eine Stimmenthaltung.Das VRBPAC stützt...

Continue reading

Chart Industries’ CEO Evanko Named 2020 Chief Trailblazer of the Year by S&P Global Platts

ATLANTA, Dec. 10, 2020 (GLOBE NEWSWIRE) — Chart Industries, Inc. (NASDAQ: GTLS) is proud to announce that CEO and President Jill Evanko has been awarded the 2020 Chief Trailblazer Award by S&P Global Platts. The S&P Global Platts Global Energy Awards is an annual program that recognizes exemplary corporate and individual innovation, leadership and superior performance. Established in 1999 and often coined “the Oscars” of the energy industry, the S&P Global Platts Global Energy Awards highlight achievement in 21 categories spanning the entire energy complex. This year, there were over 300 nominated entries from over three dozen countries.The Chief Trailblazer Award is awarded to an individual (or to a CEO of a small-mid cap company) who has consistently demonstrated clarity of vision, judgment and motivational skills...

Continue reading

The Becker Milk Company Limited: Six Month Financial Results

TORONTO, Dec. 10, 2020 (GLOBE NEWSWIRE) — The Becker Milk Company Limited (the “Company”) (TSX-BEK.B) is pleased to report the results for the six months ended October 31, 2020.HIGHLIGHTSTotal revenues for the six months ended October 31, 2020 were $1,524,336 compared to $1,618,664 for the same period in 2019;Net operating income for Q2 fiscal 2021 was $1,296,169 compared to $1,328,088 in fiscal 2020;Net income for Q2 fiscal 2021 was $ 0.23 per share, compared to $0.25 per share in fiscal 2020.FINANCIAL HIGHLIGHTSNet operating income for the six months ended October 31, 2020 was $1,296,169, a $31,919 decrease compared with the previous year as a result of decreased revenue for the quarter.Components of the $30,917 decrease in net income for the six months ended October 31, 2020 compared to the six months ended October 31, 2019 are:ADJUSTED...

Continue reading

ArcelorMittal signs investment agreement with Invitalia

 11 December, 2020, 00:10 CETArcelorMittal announces that it has signed a binding agreement (the ‘Investment Agreement’) with Invitalia, an Italian state-owned company, forming a public-private partnership between the parties. The Investment Agreement will result in a recapitalization of AM InvestCo, ArcelorMittal’s subsidiary which signed the lease and obligation to purchase agreement for Ilva’s business. Invitalia will invest in AM InvestCo in two tranches:The first investment of €400 million will be made by 31 January 2021 (subject to EU antitrust authorization), providing Invitalia with joint control over AM InvestCo;The second tranche of up to €680 million is payable on closing of AM InvestCo’s purchase of Ilva’s business, which is subject to the satisfaction of various conditions precedent* by May 2022, at which point Invitalia’s...

Continue reading

Ocugen Inc. Announces Plan to Postpone Annual Meeting of Stockholders

MALVERN, Pa., Dec. 10, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, today announced that it will postpone its 2020 Annual Meeting of Stockholders to December 23, 2020 to provide its stockholders additional time to vote on the proposals submitted for stockholder approval at the meeting.The record date for determining stockholders eligible to vote at the annual meeting will remain the close of business on October 28, 2020. Stockholders who have already submitted a proxy do not need to vote again for the reconvened annual meeting scheduled for Wednesday, December 23, 2020 at 11 a.m. Eastern time, as the proxies submitted will remain valid.Ocugen stockholders as of close of business on October...

Continue reading

Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

VANCOUVER and MINNEAPOLIS, Dec. 10, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX:NVCN), announced today that it has received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum market value requirement set forth in Nasdaq Rules for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(2) requires companies to maintain a minimum market value of US$35 million and Listing Rule 5810(c)(3)(C) provides that a failure to meet the market value requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the market value of the Company for the 30 consecutive business days from October 28,...

Continue reading

Ayr Strategies Announces Closing of 12.5% Senior Secured Notes

TORONTO, Dec. 10, 2020 (GLOBE NEWSWIRE) — Ayr Strategies Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated cannabis multi-state operator, is pleased to announce the closing of its previously announced offering of 12.5% Senior Secured Notes (the “Notes”).As part of the offering, led by Canaccord Genuity Corp., Ayr issued US$110 million of notes to a syndicate of institutional investors. The Notes will pay interest of 12.5% per annum, payable semi-annually, with a maturity 48 months from closing.The Notes contain certain covenants and restrictions on Ayr’s business, including restrictions on the incurrence of debt, asset sales and dividends and other distributions. The Notes are secured by a first-priority security interest in specified assets of Ayr and certain of its subsidiaries. As previously...

Continue reading

Orezone Announces Grant of Restricted Share Units

VANCOUVER, British Columbia, Dec. 10, 2020 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX.V: ORE OTCQX: ORZCF) announces that pursuant to its Restricted Share Unit (“RSU”) plan, the Company has granted 1,207,000 RSUs to certain officers and employees of the Company. Each RSU is exercisable into one common share of the Company upon vesting. The RSUs will vest in two equal installments on the first and second anniversaries from the date of grant.Orezone Gold CorporationOrezone Gold Corporation (TSX.V: ORE OTCQX: ORZCF) is a Canadian development company which owns a 90% interest in Bomboré, one of the largest undeveloped gold deposits in Burkina Faso.The 2019 feasibility study highlights Bomboré as an attractive shovel-ready gold project with forecasted annual gold production of 118,000 ounces over a 13+ year mine life at an All-In...

Continue reading

Globis Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering

New York, NY, Dec. 10, 2020 (GLOBE NEWSWIRE) — Globis Acquisition Corp. (NASDAQ: GLAQU, the “Company”) announced today that it priced its initial public offering of 10,000,000 units at $10.00 per unit. The units are expected to be listed on The Nasdaq Capital Market (“NASDAQ”) and trade under the ticker symbol “GLAQU” beginning on December 11, 2020. Each unit consists of one share of common stock and one redeemable warrant to purchase one share of common stock at $11.50 per share. Once the securities comprising the units begin separate trading, the common stock and warrants are expected to be listed on NASDAQ under the symbols “GLAQ” and “GLAQW”, respectively.The offering is expected to close on December 15, 2020, subject to customary closing conditions.Chardan acted as sole book running manager in the offering. The underwriters have...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.